Article Information
History
- July 31, 2024.
Article Versions
- Version 1 (February 13, 2024 - 10:08).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Federico Narvaez1,2,
- Carlos Montenegro2,
- Jose Guillermo Juarez2,
- José Victor Zambrana2,3,
- Karla Gonzalez2,4,
- Elsa Videa2,
- Sonia Arguello2,
- Fanny Barrios1,2,
- Sergio Ojeda2,
- Miguel Plazaola2,
- Nery Sanchez2,
- Daniel Camprubí-Ferrer5,a,
- Guillermina Kuan6,
- Gabriela Paz Bailey5,
- Eva Harris7 and
- Angel Balmaseda2,4,*
- 1Unidad de Infectología, Hospital Infantil Manuel de Jesús Rivera, Ministerio de Salud, Managua, Nicaragua
- 2Sustainable Sciences Institute, Managua, Nicaragua
- 3Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA
- 4Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua, Nicaragua
- 5Dengue Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, San Juan, Puerto Rico
- 6Centro de Salud Sócrates Flores Vivas, Ministerio de Salud, Managua, Nicaragua
- 7Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA
- ↵*Corresponding author: Angel Balmaseda, abalmaseda40{at}gmail.com
Posted July 31, 2024.
Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua
